Gene: SUGP2
Official Full Name: SURP and G-patch domain containing 2provided by HGNC
Gene Summary: This gene encodes a member of the arginine/serine-rich family of splicing factors. The encoded protein functions in mRNA processing. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32236 | SUGP2 Knockout cell line (HeLa) | Human | SUGP2 | 1:3~1:6 | Negative | Online Inquiry |
KO32237 | SUGP2 Knockout cell line (HCT 116) | Human | SUGP2 | 1:2~1:4 | Negative | Online Inquiry |
KO32238 | SUGP2 Knockout cell line (HEK293) | Human | SUGP2 | 1:3~1:6 | Negative | Online Inquiry |
KO32239 | SUGP2 Knockout cell line (A549) | Human | SUGP2 | 1:3~1:4 | Negative | Online Inquiry |
SUGP2 Gene Knockout Cell Lines are specialized cell lines in which the SUGP2 gene has been precisely deleted or modified through advanced gene editing technologies, such as CRISPR-Cas9. This deletion results in the loss of normal SUGP2 protein function, allowing researchers to study the gene's biological role, its interactions within various cellular pathways, and its implications in disease. The knockout of SUGP2 is particularly valuable as this gene is implicated in critical biological processes such as RNA metabolism, chromatin remodeling, and stress response mechanisms.
The primary function of SUGP2 Gene Knockout Cell Lines is to facilitate functional assays that explore the phenotypic consequences of SUGP2 deficiency. By observing cellular behaviors such as proliferation, differentiation, and apoptosis in the absence of SUGP2, researchers can elucidate its contributions to cellular homeostasis and disease states. The cell lines serve as an important model system for investigating conditions such as cancer, where dysregulation of gene expression and protein function plays a pivotal role.
The scientific importance of these knockout cell lines extends all the way to application in translational research and therapeutic development. Understanding the modulation of cellular pathways in the context of SUGP2 deficiency can guide drug discovery efforts and the development of targeted therapies. Furthermore, elucidating the role of SUGP2 may advance our understanding of complex diseases and identify novel biomarkers for early diagnosis.
Compared to traditional cell lines that express functional SUGP2, our SUGP2 Gene Knockout Cell Lines offer unparalleled specificity and accuracy in studying the gene's biological impact. This precise gene knockout provides clarity in experimental outcomes, reducing background noise and ensuring that observed effects are directly attributable to changes in SUGP2 function.
Researchers and clinicians utilizing these cell lines benefit from reliable and reproducible data, driving more effective hypotheses and experiments. The ability to modulate and study a specific gene in isolation allows for the optimization of experimental conditions and innovative research strategies, enhancing the productivity of any research program.
At [Company Name], we are committed to advancing scientific knowledge through high-quality biological products. Our expertise in cell line development and gene editing technologies ensures that our SUGP2 Gene Knockout Cell Lines meet the highest standards of performance and reliability, empowering researchers to achieve impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.